CD133 (prominin-1) is a pentaspan glycoprotein over-expressed on several types of CSCs and is an independent prognostic factor for clinical outcome in patients with malignant glioma and colon and breast carcinomas [12,13,14,15]. This evidence concerns the gene PROM1 and breast carcinoma.